G. Gary Tian, MD, PhD, is a Medical Oncologist and Hematologist at West Cancer Center.
Titles and Roles
- Medical Oncologist and Hematologist, West Cancer Center
- National Comprehensive Cancer Network (NCCN) Guidelines Committee on Hepatobiliary Cancers
- Assistant Professor of Medicine, the University of Tennessee Health Science Center
- Clinical Pathway Committee, West Cancer Center
- Former Chair, pharmacy committee at St. Francis Hospital, Bartlett, TN
Areas of Expertise
- Medical Oncology
Board certified in Medical Oncology and Internal Medicine, Dr. Tian specializes in Oncology/Hematology and is licensed to practice in Maryland, Mississippi, Tennessee and Arkansas. Dr. Tian has been in practice in the Memphis area since 2003. He is a member of the American Society of Clinical Oncology, the American Society of Hematology and the American College of Physicians. Dr. Tian specializes in Oncology and Hematology with particular interests in lung cancer, colorectal and breast cancer. Dr. Tian believes in teaching patients about their illness in order to help them better understand the disease process and treatment options. His scientific background lends to the philosophy of bringing cancer care “from bench to bedside.” Outside his practice, Dr. Tian enjoys traveling, spending time with his family and playing various sports. He has been an avid soccer player since college. He also enjoys playing golf, roller-skating, and skiing.
Education and Training
Dr. Tian began his higher education at Peking University, Peking P.R. China where he received his B.S. in Pre-Med Sciences. Dr. Tian left China to come to the U.S. in order to pursue his interests in the sciences. He studied gene regulation in carcinogenesis and earned his Master’s Degree in Biochemistry from Rutgers University, New Brunswick, New Jersey. Dr. Tian continued his research at Brandeis University, Waltham, Massachusetts, and was awarded a PhD in Molecular and Cell Biology. His research included gene regulation in immunoglobulin and T cell activation, which have been shown to be critical in pathogenesis in leukemias, lymphomas and multiple myeloma. Dr. Tian’s research was well published in peer reviewed journals; and although Dr. Tian had become an accomplished scientist, he decided to return to Peking Union Medical College in 1996 in order to complete his studies in clinical medicine and obtain his medical degree. After earning his MD, Dr. Tian returned to the states where he completed his internship and residency in Internal medicine at The St. Vincent Catholic Medical Centers in Queens, New York. His oncology/hematology fellowship was completed at University of Maryland Medical Center in Baltimore, Maryland.
Dr. Tian is a principle investigator with the phase I and phase II clinical trials at West Cancer Center.
Dr. Tian has published many articles and posters/abstracts, most recently appearing in the American Society of Clinical Oncology, as well as the American Association for Cancer Research.
To view Dr. Tian’s most recent publications, click here.